Title: Isolation and structure determination of oxidative degradation products of atorvastatin.
Journal: Journal of pharmaceutical and biomedical analysis 20091205
1246818-88-1
1046118-44-8
141022-99-3 | 2-Heptadecanone, 1,1,1-trifluoro- | AA001FO1 | MFCD00797669
1414973-10-6 | 2-(Hydroxymethyl)pyridine-4-boronic acid | AA001GEX | MFCD22205764
1416440-75-9 | 7-(tert-Butoxycarbonylamino)quinoline-3-carboxylic acid | AA001GQ6 | MFCD22690563
77110-11-3 | Dibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin, 6,7,9,10,17,18,20,21-octahydro-, homopolymer | AA01X3QR | MFCD00005098
1420800-39-0 | 3-Bromo-2-(chloromethyl)pyridine HCl | AA001HN2 | MFCD22689127
14228-23-0 | 2-(4-Pyridinyl)-4-quinolinecarboxylic acid | AA001I1X | MFCD00687610
143924-45-2 | 2-(Piperidin-4-yl)pyridine dihydrochloride | AA001IJH | MFCD14583122
144163-85-9 | [(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-carbamic acid 1,1-dimethylethyl ester | AA001IYK | MFCD09833420
14447-18-8 | Benzyl cyanoacetate | AA001JJC | MFCD00051719
144690-07-3 | Ethyl 5-acetyl-2-propyl-1H-imidazole-4-carboxylate | AA001JXG | MFCD18910535